SCHEMBL30106286

SCHEMBL30106286

CC(C)(C)OC(=O)NCCNC(=O)c1nc(-c2ccc(C(F)(F)F)cc2)oc1-c1ccccc1[N+](=O)[O-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF4E P06730 3/20 0.41
POLB P06746 1/20 0.41
S1PR1 P21453 1/20 0.38
TRPV1 Q8NER1 1/20 0.38
LMNA P02545 2/20 0.37
DGAT1 O75907 1/20 0.36
ATR Q13535 1/20 0.36
ALDH1A1 P00352 1/20 0.36
ABCG2 Q9UNQ0 1/20 0.36
IKBKB O14920 1/20 0.36
MALT1 Q9UDY8 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35
CRHBP P24387 1/20 0.35
CYP2C19 P33261 1/20 0.35
CRHR2 Q13324 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29158753 0.89 EIF4E (0.44) EIF4EPOLBTRPV1LMNADGAT1
SCHEMBL29158587 0.88 TRPV1 (0.46) EIF4EPOLBTRPV1LMNADGAT1
SCHEMBL29158589 0.86 EIF4E (0.45) EIF4EPOLBTRPV1LMNADGAT1
SCHEMBL30106335 0.86 GAA (0.43) EIF4EPOLBTRPV1LMNADGAT1
SCHEMBL29158703 0.86 EIF4E (0.43) EIF4EPOLBTRPV1LMNADGAT1
SCHEMBL29158612 0.86 EIF4E (0.43) EIF4EPOLBTRPV1LMNAALDH1A1
SCHEMBL27189036 0.85 ACKR3 (0.44) EIF4EPOLBLMNAMEN1KMT2A
SCHEMBL29158660 0.85 EIF4E (0.42) EIF4EPOLBTRPV1LMNAALDH1A1
SCHEMBL30106366 0.84 POLB (0.53) EIF4EPOLBLMNAALDH1A1IKBKB
SCHEMBL29158684 0.83 POLB (0.44) EIF4EPOLBLMNADGAT1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240287052-A1 NOVEL OXAZOLE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASES COMPRISING THE SAME AZCURIS CO., LTD. (KR) 2024-08-29 US claimed
EP-4349818-A1 NOVEL OXAZOLE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME FOR PREVENTION OR TREATMENT OF ALLERGIC DISEASE Azcuris Co., Ltd. (KR) 2024-04-10 EP claimed
WO-2022255764-A1 NOVEL OXAZOLE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME FOR PREVENTION OR TREATMENT OF ALLERGIC DISEASE 주식회사 에즈큐리스 2022-12-08 WO claimed
US-20240287052-A1 NOVEL OXAZOLE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASES COMPRISING THE SAME AZCURIS CO., LTD. (KR) 2024-08-29 US disclosed
EP-4349818-A1 NOVEL OXAZOLE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME FOR PREVENTION OR TREATMENT OF ALLERGIC DISEASE Azcuris Co., Ltd. (KR) 2024-04-10 EP disclosed
WO-2022255764-A1 NOVEL OXAZOLE DERIVATIVE AND PHARMACEUTICAL COMPOSITION CONTAINING SAME FOR PREVENTION OR TREATMENT OF ALLERGIC DISEASE 주식회사 에즈큐리스 2022-12-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240287052-A1 NOVEL OXAZOLE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALLERGIC DISEASES COMPRISING THE SAME IL33, TSLP, IL5 EIF4E 3640/4885POLB 3636/4885S1PR1 2555/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.